List of Tables
    Table 1. Postmenopausal Osteoporosis Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Postmenopausal Osteoporosis Drugs Market Trends
    Table 3. Postmenopausal Osteoporosis Drugs Market Drivers
    Table 4. Postmenopausal Osteoporosis Drugs Market Challenges
    Table 5. Postmenopausal Osteoporosis Drugs Market Restraints
    Table 6. Global Postmenopausal Osteoporosis Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Postmenopausal Osteoporosis Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Postmenopausal Osteoporosis Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Postmenopausal Osteoporosis Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Postmenopausal Osteoporosis Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Postmenopausal Osteoporosis Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Postmenopausal Osteoporosis Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Postmenopausal Osteoporosis Drugs Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Postmenopausal Osteoporosis Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Postmenopausal Osteoporosis Drugs Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Postmenopausal Osteoporosis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Postmenopausal Osteoporosis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postmenopausal Osteoporosis Drugs as of 2021)
    Table 18. Top Players of Postmenopausal Osteoporosis Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Postmenopausal Osteoporosis Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Postmenopausal Osteoporosis Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Postmenopausal Osteoporosis Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Postmenopausal Osteoporosis Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Postmenopausal Osteoporosis Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Postmenopausal Osteoporosis Drugs Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Postmenopausal Osteoporosis Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Postmenopausal Osteoporosis Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Postmenopausal Osteoporosis Drugs Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Postmenopausal Osteoporosis Drugs Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Postmenopausal Osteoporosis Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Postmenopausal Osteoporosis Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Postmenopausal Osteoporosis Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Postmenopausal Osteoporosis Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Postmenopausal Osteoporosis Drugs Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Postmenopausal Osteoporosis Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Postmenopausal Osteoporosis Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Postmenopausal Osteoporosis Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Postmenopausal Osteoporosis Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Postmenopausal Osteoporosis Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Postmenopausal Osteoporosis Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Postmenopausal Osteoporosis Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Eli Lilly Corporation Information
    Table 43. Eli Lilly Description and Business Overview
    Table 44. Eli Lilly Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Eli Lilly Postmenopausal Osteoporosis Drugs Product
    Table 46. Eli Lilly Recent Development
    Table 47. Amgen Corporation Information
    Table 48. Amgen Description and Business Overview
    Table 49. Amgen Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Amgen Product
    Table 51. Amgen Recent Development
    Table 52. Merck Corporation Information
    Table 53. Merck Description and Business Overview
    Table 54. Merck Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. Merck Product
    Table 56. Merck Recent Development
    Table 57. Novartis Corporation Information
    Table 58. Novartis Description and Business Overview
    Table 59. Novartis Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Novartis Product
    Table 61. Novartis Recent Development
    Table 62. Allergan Corporation Information
    Table 63. Allergan Description and Business Overview
    Table 64. Allergan Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Allergan Product
    Table 66. Allergan Recent Development
    Table 67. Amgen Astellas Biopharm Corporation Information
    Table 68. Amgen Astellas Biopharm Description and Business Overview
    Table 69. Amgen Astellas Biopharm Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. Amgen Astellas Biopharm Product
    Table 71. Amgen Astellas Biopharm Recent Development
    Table 72. Deltanoid Pharmaceuticals Corporation Information
    Table 73. Deltanoid Pharmaceuticals Description and Business Overview
    Table 74. Deltanoid Pharmaceuticals Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. Deltanoid Pharmaceuticals Product
    Table 76. Deltanoid Pharmaceuticals Recent Development
    Table 77. Noven Corporation Information
    Table 78. Noven Description and Business Overview
    Table 79. Noven Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. Noven Product
    Table 81. Noven Recent Development
    Table 82. Novo Nordisk Corporation Information
    Table 83. Novo Nordisk Description and Business Overview
    Table 84. Novo Nordisk Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. Novo Nordisk Product
    Table 86. Novo Nordisk Recent Development
    Table 87. Osteologix Corporation Information
    Table 88. Osteologix Description and Business Overview
    Table 89. Osteologix Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 90. Osteologix Product
    Table 91. Osteologix Recent Development
    Table 92. Pfizer Corporation Information
    Table 93. Pfizer Description and Business Overview
    Table 94. Pfizer Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 95. Pfizer Product
    Table 96. Pfizer Recent Development
    Table 97. PhytoHealth Corporation Information
    Table 98. PhytoHealth Description and Business Overview
    Table 99. PhytoHealth Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 100. PhytoHealth Product
    Table 101. PhytoHealth Recent Development
    Table 102. Radius Health Corporation Information
    Table 103. Radius Health Description and Business Overview
    Table 104. Radius Health Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 105. Radius Health Product
    Table 106. Radius Health Recent Development
    Table 107. Tarsa Therapeutics Corporation Information
    Table 108. Tarsa Therapeutics Description and Business Overview
    Table 109. Tarsa Therapeutics Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 110. Tarsa Therapeutics Product
    Table 111. Tarsa Therapeutics Recent Development
    Table 112. Key Raw Materials Lists
    Table 113. Raw Materials Key Suppliers Lists
    Table 114. Postmenopausal Osteoporosis Drugs Customers List
    Table 115. Postmenopausal Osteoporosis Drugs Distributors List
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Postmenopausal Osteoporosis Drugs Product Picture
    Figure 2. Global Postmenopausal Osteoporosis Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Postmenopausal Osteoporosis Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Postmenopausal Osteoporosis Drugs Sales 2017-2028 (K Pcs)
    Figure 5. United States Postmenopausal Osteoporosis Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Postmenopausal Osteoporosis Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Postmenopausal Osteoporosis Drugs Sales 2017-2028 (K Pcs)
    Figure 8. United States Postmenopausal Osteoporosis Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Postmenopausal Osteoporosis Drugs Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Postmenopausal Osteoporosis Drugs Report Years Considered
    Figure 11. Product Picture of Antiresorptive Medications
    Figure 12. Product Picture of Anabolic Medications
    Figure 13. Global Postmenopausal Osteoporosis Drugs Market Share by Type in 2022 & 2028
    Figure 14. Global Postmenopausal Osteoporosis Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Postmenopausal Osteoporosis Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Postmenopausal Osteoporosis Drugs Sales by Type (2017-2028) & (K Pcs)
    Figure 17. Global Postmenopausal Osteoporosis Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Postmenopausal Osteoporosis Drugs Price by Type (2017-2028) & (USD/Pcs)
    Figure 19. United States Postmenopausal Osteoporosis Drugs Market Share by Type in 2022 & 2028
    Figure 20. United States Postmenopausal Osteoporosis Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Postmenopausal Osteoporosis Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Postmenopausal Osteoporosis Drugs Sales by Type (2017-2028) & (K Pcs)
    Figure 23. United States Postmenopausal Osteoporosis Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Postmenopausal Osteoporosis Drugs Price by Type (2017-2028) & (USD/Pcs)
    Figure 25. Product Picture of Hospital
    Figure 26. Product Picture of Pharmacy
    Figure 27. Product Picture of Other
    Figure 28. Global Postmenopausal Osteoporosis Drugs Market Share by Application in 2022 & 2028
    Figure 29. Global Postmenopausal Osteoporosis Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Postmenopausal Osteoporosis Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Postmenopausal Osteoporosis Drugs Sales by Application (2017-2028) & (K Pcs)
    Figure 32. Global Postmenopausal Osteoporosis Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Postmenopausal Osteoporosis Drugs Price by Application (2017-2028) & (USD/Pcs)
    Figure 34. United States Postmenopausal Osteoporosis Drugs Market Share by Application in 2022 & 2028
    Figure 35. United States Postmenopausal Osteoporosis Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Postmenopausal Osteoporosis Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Postmenopausal Osteoporosis Drugs Sales by Application (2017-2028) & (K Pcs)
    Figure 38. United States Postmenopausal Osteoporosis Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Postmenopausal Osteoporosis Drugs Price by Application (2017-2028) & (USD/Pcs)
    Figure 40. North America Postmenopausal Osteoporosis Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 41. North America Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Postmenopausal Osteoporosis Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 45. Europe Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Postmenopausal Osteoporosis Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 52. Asia-Pacific Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Postmenopausal Osteoporosis Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 64. Latin America Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Postmenopausal Osteoporosis Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 69. Middle East & Africa Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. UAE Postmenopausal Osteoporosis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Postmenopausal Osteoporosis Drugs Value Chain
    Figure 74. Postmenopausal Osteoporosis Drugs Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed